Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development

E-ISSN： 1873-4286|12|18|2319-2325

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.18, 2006-06, pp. : 2319-2325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endocannabinoids New Targets for Drug Development

Current Pharmaceutical Design, Vol. 6, Iss. 13, 2000-09 ,pp. : 1361-1380

Bentham Science Publishers

Access to resources Recommend Favorite

Down-Regulation of Notch1 Expression is Involved in HL-60 Cell Growth Inhibition Induced by 4-Hydroxynonenal, a Product of Lipid Peroxidation

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 551-557

Bentham Science Publishers

Access to resources Recommend Favorite

Protease-mediated signalling: new paradigms for cell regulation and drug development

By Hollenberg M.D.

Trends in Pharmacological Sciences, Vol. 17, Iss. 1, 1996-01 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite

Lipid Mediators in Inflammatory Disorders

By Heller A.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 487-496

Adis International

Access to resources Recommend Favorite

Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 11, 2012-09 ,pp. : 1119-1126

Bentham Science Publishers

Access to resources Recommend Favorite